About Us

BioVentrix, Inc. is an innovative medical device company serving cardiothoracic surgeons and their patients with lifesaving heart failure therapies. BioVentrix technologies aim to improve cardiac function by directly addressing LV dilation.

The BioVentrix Revivent System is designed to support a less invasive procedure to treat a dilated left ventricle of patients with ischemic heart failure with reduced ejection fraction (HFrEF) and extensive left ventricular scar, who have a suboptimal response to guideline-directed medical therapy. The procedure uses myocardial micro-anchor implants to reconstruct the dilated left ventricle to produce a more efficient chamber. The system has CE Mark certification.

Management Team

Steven Chartier

President and Co-Chief Executive Officer

David Richmond

Co-Chief Executive Officer

Carl Byrnes

Chief Financial Officer

Ori Ben-Yehuda, MD

Medical Consultant

Larry Brubach

VP, Therapy Development

Fabio Felix

Director, Manufacturing

Dan Stack

Director, Quality

Tim Kowalewski

Director of Therapy Development

Ganiat Idris

Clinical Project Manager

Board of Directors

Steven Chartier

President and Co-Chief Executive Officer

David Richmond

Co-Chief Executive Officer

William T. Abraham

MD
Chief Medical Officer,
V-Wave Ltd., Professor of Medicine, Physiology and Cell Biology, The Ohio State University

Rishi Puri

MD, PhD, FRACP
Coronary and Structural Heart Disease Interventional Cardiologist, Cleveland Clinic

Mark R. Ravich

BSE, MBA
President, Tri-Star Management, Inc.